Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15569859 | 0.74 | KMT2A (0.36) | — | |
| SCHEMBL17005371 | 0.68 | MAPK1 (0.49) | MAPK1CHEK1 | |
| SCHEMBL29488969 | 0.68 | MAPK1 (1.00) | MAPK1CHEK1 | |
| SCHEMBL30259037 | 0.68 | MAPK1 (0.62) | MAPK1CHEK1 | |
| SCHEMBL650607 | 0.68 | MAPK1 (0.62) | MAPK1CHEK1 | |
| SCHEMBL31229864 | 0.68 | MAPK1 (0.49) | MAPK1CHEK1 | |
| SCHEMBL12657766 | 0.63 | MAPK1 (0.67) | MAPK1CHEK1 | |
| SCHEMBL30399933 | 0.62 | CHEK1 (0.40) | MAPK1CHEK1 | |
| SCHEMBL15570080 | 0.62 | MAPK1 (0.48) | MAPK1 | |
| SCHEMBL1017711 | 0.62 | CHEK1 (0.56) | MAPK1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210107908-A1 | PHARMACEUTICAL COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-04-15 | — | — | US | disclosed |
| CN-111902415-A | Pharmaceutical compounds | 大冢制药株式会社 | 2020-11-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210107908-A1 | PHARMACEUTICAL COMPOUNDS | MAPT, CYP3A5, SLC5A1 | MAPK1 2041/4885CHEK1 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.